[-] Show simple item record

dc.contributor.authorKerns, J. William
dc.contributor.authorMabry, Sandi
dc.date.issued2001-10eng
dc.description.abstractWomen on standard estrogen/progestin hormone replacement therapy (HRT) regimens frequently have irregular bleeding during the first 12 months of treatment. Therefore, those taking HRT should usually be evaluated after 1 year of treatment if bleeding continues. (Grade of recommendation: C, based on case series.) Evaluation of this bleeding should begin with a pelvic examination and Papanicolaou (Pap) test (if not done in the previous 12 months), then transvaginal ultrasound (TVUS), followed by endometrial biopsy or hysteroscopy, if indicated. (Grade: B, based on a systematic review of studies.)en
dc.identifier.urihttp://hdl.handle.net/10355/2817
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofClinical Inquiries, 2001 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subjectendometrial biopsyen
dc.subjecthormone replacement therapy (HRT)en
dc.subjectvaginal bleedingen
dc.subject.lcshMenopause Hormone Therapyen
dc.subject.lcshHysteroscopyen
dc.subject.lcshEndometriumen
dc.subject.lcshBiopsyen
dc.subject.lcshGynecologyen
dc.titleWhat is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?en
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record